StockData
Neurocrine Biosciences Inc logo

Neurocrine Biosciences Inc (NBIX) stock

NBIXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/306% below fair value
$162.86−3.06 (-1.84%)

Close on Nov 18, 2026Market cap $16.55BP/E 23.9Yield –

Neurocrine Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Neurocrine Biosciences

Neurocrine Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Neurocrine Biosciences figures

See a number that looks wrong?